Laboratory parameters | Onset | 2 weeks after HLH-treatment was started | 6 weeks before HSCT | 12 months after HSCT |
---|---|---|---|---|
White blood counts (6-17 × 103/uL) | 3.4 | 14.54 | 5.4 | 10.1 |
Neutrophils (1.68–8.5 × 103/uL) | 2.33 | 12.51 | 3.86 | 4.3 |
Lymphocytes (3–11.2 × 103/uL) | 0.5 | 0.34 | 0.62 | 8.51 |
Haemoglobin (10.5–15.5 g/dl) | 7.1 | 8.0 | 8.0 | 10.9 |
Platelet (150-450 × 103/uL) | 360 | 377 | 406 | 393 |
Ferritin (17–390 ng/ml) | 24,716 | 25 | 2051 | 34 |
Fibrinogen (200–500 mg/dl) | 253 | 240 | 219 | 208 |
D-dimer (< 0.5 microg/ml) | 2.81 | 0.35 | 0.5 | 0.25 |
PTT (25–34 s) | 27.3 | 25.2 | 33 | 31.9 |
PT (12.1–14.5 s) | 13 | 13.4 | 12 | 13.3 |
PT RATIO-INR (0.92–1.14 s) | 1.07 | 1.13 | 0.92 | 1.07 |
Triglycerides (40–150 mg/dl) | 247 | 111 | 316 | 110 |
AST (5–40 UI/L) | 97 | 40 | 48 | 32 |
ALT (5–40 UI/L) | 27 | 18 | 14 | 34 |
LDH (100–600 UI/L) | 2217 | 525 | 869 | 385 |
CRP (0–0.5 mg/dl) | 4.18 | < 0.05 | 0.07 | 0.05 |
IL-18 (pg/ml)a | 250,000 | 83,200 | 113,789 | 1024 |
CXCL9 (pg/ml)a | 3556 | 4942 | 3327 | < 300 |